ConductScience.org, home

Paper · 41370732

Clinical Outcomes of Adult Patients With Newly Diagnosed Mixed Phenotype Acute Leukemia.

Goulart H and 27 others. JCO Precis Oncol, 2025. Cited by 2 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Clinical Outcomes of Adult Patients With Newly Diagnosed Mixed Phenotype Acute Leukemia. Papers, record 41370732. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41370732

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Clinical Outcomes of Adult Patients With Newly Diagnosed Mixed Phenotype Acute Leukemia.
PubMed
Journal
JCO Precis Oncol
PubMed
Year
2025
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
2
iCite
Revised in PubMed
2026-11-04
PubMed

Authors28

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Leukemia, Biphenotypic, AcuteMajor topic
Humans
Male
Female
Aged
Middle Aged
Retrospective Studies
Adult
Aged, 80 and over
Treatment Outcome

Source PubMed

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P30 CA016672NCI NIH HHSUnited StatesP30CA016672PubMed and NIHNIH RePORTER
P50 CA100632NCI NIH HHSUnited StatesP50CA100632PubMed and NIHNIH RePORTER

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References23

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135,797,463Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN.Blood2022https://conductscience.org/library/papers/35797463PubMed
221,266,800Clinical characteristics, biological profile, and outcome of biphenotypic acute leukemia: a case series.Acta Haematol2011https://conductscience.org/library/papers/21266800PubMed
37,564,526Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL).Leukemia1995https://conductscience.org/library/papers/7564526PubMed
425,605,373How I treat mixed-phenotype acute leukemia.Blood2015https://conductscience.org/library/papers/25605373PubMed
529,550,836Therapy for children and adults with mixed phenotype acute leukemia: a systematic review and meta-analysis.Leukemia2018https://conductscience.org/library/papers/29550836PubMed
62,031,964A classification of acute leukaemia for the 1990s.Ann Hematol1991https://conductscience.org/library/papers/2031964PubMed
740,105,906Therapeutic horizon of acute myeloid leukemia: Success, optimism, and challenges.Cancer2025https://conductscience.org/library/papers/40105906PubMed
827,069,254The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.Blood2016https://conductscience.org/library/papers/27069254PubMed
924,146,232Diagnosing and treating mixed phenotype acute leukemia: a multicenter 10-year experience in México.Ann Hematol2014https://conductscience.org/library/papers/24146232PubMed
1033,618,432Flow cytometric immunophenotypic alterations of persistent clonal haematopoiesis in remission bone marrows of patients with NPM1-mutated acute myeloid leukaemia.Br J Haematol2021https://conductscience.org/library/papers/33618432PubMed

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn Papers
42,867,742Venetoclax combined with olverembatinib and prednisone as a frontline therapeutic strategy for Philadelphia chromosome-positive mixed-phenotype acute leukemia.Blood Res2026https://conductscience.org/library/papers/42867742

Source PubMed

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
TP537,157PubTator's text mininghttps://conductscience.org/library/genes/7157

Source NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41370732

GET https://conductscience.org/api/papers/v1/41370732/authors?page=2